Sionna Therapeutics, Inc. (SION)
Nasdaq: SION · CIK 0002036042 · United States
Every official Sionna Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open SION filings
Sionna Therapeutics, Inc. documents
- Sionna Therapeutics, Inc. 10-K 2026SION 10-K 2026: annual report for fiscal 2026
- Sionna Therapeutics, Inc. 10-K 2025SION 10-K 2025: annual report for fiscal 2025
- Sionna Therapeutics, Inc. 10-K 2024SION 10-K 2024: annual report for fiscal 2024
- Sionna Therapeutics, Inc. 10-K 2023SION 10-K 2023: annual report for fiscal 2023
- Sionna Therapeutics, Inc. 10-K 2022SION 10-K 2022: annual report for fiscal 2022
- Sionna Therapeutics, Inc. 10-Q 2026SION 10-Q 2026: quarterly report for fiscal 2026
- Sionna Therapeutics, Inc. 10-Q 2025SION 10-Q 2025: quarterly report for fiscal 2025
- Sionna Therapeutics, Inc. 10-Q 2024SION 10-Q 2024: quarterly report for fiscal 2024
- Sionna Therapeutics, Inc. 10-Q 2023SION 10-Q 2023: quarterly report for fiscal 2023
- Sionna Therapeutics, Inc. 10-Q 2022SION 10-Q 2022: quarterly report for fiscal 2022
- Sionna Therapeutics, Inc. 8-K 2026SION 8-K 2026: current report for fiscal 2026
- Sionna Therapeutics, Inc. 8-K 2025SION 8-K 2025: current report for fiscal 2025
- Sionna Therapeutics, Inc. 8-K 2024SION 8-K 2024: current report for fiscal 2024
- Sionna Therapeutics, Inc. 8-K 2023SION 8-K 2023: current report for fiscal 2023
- Sionna Therapeutics, Inc. 8-K 2022SION 8-K 2022: current report for fiscal 2022
- Sionna Therapeutics, Inc. DEF 14A 2026SION DEF 14A 2026: proxy statement for fiscal 2026
- Sionna Therapeutics, Inc. DEF 14A 2025SION DEF 14A 2025: proxy statement for fiscal 2025
- Sionna Therapeutics, Inc. DEF 14A 2024SION DEF 14A 2024: proxy statement for fiscal 2024
- Sionna Therapeutics, Inc. DEF 14A 2023SION DEF 14A 2023: proxy statement for fiscal 2023
- Sionna Therapeutics, Inc. DEF 14A 2022SION DEF 14A 2022: proxy statement for fiscal 2022
- Sionna Therapeutics, Inc. Form 4 2026SION Form 4 2026: insider trading filing for fiscal 2026
- Sionna Therapeutics, Inc. Form 4 2025SION Form 4 2025: insider trading filing for fiscal 2025
- Sionna Therapeutics, Inc. Form 4 2024SION Form 4 2024: insider trading filing for fiscal 2024
- Sionna Therapeutics, Inc. Form 4 2023SION Form 4 2023: insider trading filing for fiscal 2023
- Sionna Therapeutics, Inc. Form 4 2022SION Form 4 2022: insider trading filing for fiscal 2022
- Sionna Therapeutics, Inc. S-1 2026SION S-1 2026: registration statement for fiscal 2026
- Sionna Therapeutics, Inc. S-1 2025SION S-1 2025: registration statement for fiscal 2025
- Sionna Therapeutics, Inc. S-1 2024SION S-1 2024: registration statement for fiscal 2024
- Sionna Therapeutics, Inc. S-1 2023SION S-1 2023: registration statement for fiscal 2023
- Sionna Therapeutics, Inc. S-1 2022SION S-1 2022: registration statement for fiscal 2022
- Sionna Therapeutics, Inc. 13F 2026SION 13F 2026: institutional holdings for fiscal 2026
- Sionna Therapeutics, Inc. 13F 2025SION 13F 2025: institutional holdings for fiscal 2025
- Sionna Therapeutics, Inc. 13F 2024SION 13F 2024: institutional holdings for fiscal 2024
- Sionna Therapeutics, Inc. 13F 2023SION 13F 2023: institutional holdings for fiscal 2023
- Sionna Therapeutics, Inc. 13F 2022SION 13F 2022: institutional holdings for fiscal 2022
More companies